Wright Medical Group, Inc., an orthopaedic medical device company, engages in the design, manufacture, and marketing of reconstructive joint devices and biologics products in the United States and internationally. The reconstructive joint devices are used to replace knee, hip, and other joints that have deteriorated or have been damaged through disease or injury; and biologics are used to replace damaged or diseased bone to stimulate bone growth and to provide other biological solutions for surgeons and their patients. The company offers products in knee reconstruction, hip reconstruction, extremity reconstruction, and biologics market sectors. Wright Medical Group sells its products in the United States primarily through a network of employee sales representatives and independent sales representatives; and internationally by a combination of employee sales representatives, independent sales representatives, and stocking distributors. The company offers its products in approximately 60 countries with principal markets in the United States, Europe, and Japan. Wright Medical Group was founded in 1950 and is headquartered in Arlington, Tennessee.

-The company announced the launch of the DYNASTY BIOFOAM Acetabular Cup System. This latest addition to the DYNASTY system features proprietary bone-like titanium with a roughened texture that “bites” into bone for enhanced immediate fixation when compared to traditional porous beads. The BIOFOAM material also features a trabecular structure intended to mimic bone and contribute to bone in-growth and biological fixation.

-Second-quarter net income was $2.4 million, or 6 cents a share, compared with a net loss of $2.4 million, or a loss of 6 cents a share, in the year-ago period. Net sales were $118.9 million.

-The company will host a conference call on Thursday, October 29, 2009 at 3:30 p.m. Central Time to discuss the Company’s operating results for its third quarter ended September 30, 2009. Operating results will be released at 3:00 p.m. Central Time that day.

-WMGI added 2.91%, to $17.71 today. It has a market cap of 683.73 million and has traded within a 52-week range of $11.17 and $25.99. WMGI is currently above its 20-day moving average of $17.29 and above its 250-day moving average of $16.92. It has near-term technical support in the $16.39 price area. If the shares can continue the recent rebound, we see overhead resistance around the $18.38 price levels. Technical indicator for the stock is strong buy. Here is the chart: